| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in CAR T-cell therapies and ongoing positive clinical trial results for investigational therapies have highlighted Gilead Sciences' commitment to innovative cancer treatments. The efficacy and safety of products like Yescarta continue to show promise, particularly in difficult-to-treat conditions such as lymphoma. Additionally, the Gilead Foundation's support for cancer patients enhances the company's reputation and demonstrates a commitment to patient care. However, the recent cessation of late-stage trials for a cancer drug combination raises concerns about the challenges in product development and could impact investor confidence. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.1 is modestly bearish. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.8, and the negative at -0.1 on 2025-12-12. The forces of Sector Price Trend (-0.4), and Stock Price Trend (-0.1) will drive down the price. The forces of Price Level Sentiment (0.5), Valuation Sentiment (0.8), Market Risk Appetite (0.8), Sentiment towards Fundamentals (1.1), and Option Sentiment (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| GILD | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 0%(0%) | 120.41 | 12 | -2.29% | -0.41% | -0.1 | 0.08% | 1.2% | 0.7 | Long | 70% | 1.1 | -1 |
| 2025-12-11 | 0%(0%) | 123.23 | 36 | 1.53% | -0.32% | 0.8 | 0.08% | 1.4% | 0.8 | Long | 65% | 2.6 | -1 |
| 2025-12-10 | 0%(0%) | 121.37 | 16 | 1.68% | -0.48% | -0.4 | -0.08% | 0.7% | 0.4 | Short | 65% | 2.3 | -1 |
| 2025-12-09 | 0%(0%) | 119.37 | -7 | -1.5% | -0.48% | -0.4 | -0.08% | 0.7% | 0.7 | Long | 70% | 2.7 | -1 |
| 2025-12-08 | 0%(0%) | 121.19 | 16 | -0.02% | -0.4% | -0.3 | -0.08% | 0.9% | 0.6 | Wait | 50% | 2.7 | -1 |
| 2025-12-07 | 0%(0%) | -0.2 | -0.08% | 0.1 | 2.8 | -1 | |||||||
| 2025-12-06 | 0%(0%) | -0.2 | -0.08% | 0.1 | 2.8 | -1 | |||||||
| 2025-12-05 | 0%(0%) | 121.22 | 20 | -1.14% | -0.32% | -0.2 | -0.08% | 1.2% | 0.5 | Short | 65% | 2.3 | -1 |
| 2025-12-04 | 0%(0%) | 122.62 | 31 | -1.9% | -0.48% | -0.7 | -0.18% | 0.5% | 0.7 | Short | 60% | 2.3 | -1 |
| 2025-12-03 | 0%(0%) | 125 | 55 | 0.88% | -0.16% | 0.1 | 0.03% | 0.3% | 1 | Long | 70% | 2.6 | -1 |
| Long is the preferred trading strategy with 70% chance of being right. The rebound is expected after the huge price drop today. The trend sentiment and hourly trend are not too bearish. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-12-12 17:09:37 The discontinuation of a trial due to lack of survival benefit raises concerns about the risks involved in research and development activities, particularly in oncology. |
| 2025-12-12 17:09:37 The overall investor sentiment is likely negative due to the poorer than expected performance of Gilead's drug trial, which could influence future earnings projections. |
| 2025-12-12 17:09:37 The news reflects broader issues within the pharmaceutical industry regarding the effectiveness of cancer treatments and the competition in drug development. |
| 2025-12-12 17:09:37 The cessation of the late-stage trial for Gilead's cancer drug combination highlights challenges in product development and the potential for investor disappointment. |
| 2025-12-12 17:09:37 The significant decline in Gilead Sciences' stock price indicates negative market sentiment and potential concerns about the company's short-term outlook. |